CPEB2 and Miyoshi myopathy: In the future, more MM patients should be included, and clinical data should be collected to analyze the relationship between CPEB2 expression and the prognosis of MM patients, so as to provide evidence that CPEB2 may be a potential biomarker of MM prognosis.